株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

中国のOTC医薬品市場および薬局小売(2010年):市場分析

OTC Pharmaceuticals & Pharmacy Retailing in China 2010: A Market Analysis

発行 Mintel China 商品コード 124522
出版日 ページ情報 英文 125 Pages
納期: 即日から翌営業日
価格
こちらの商品の販売は終了いたしました。
Back to Top
中国のOTC医薬品市場および薬局小売(2010年):市場分析 OTC Pharmaceuticals & Pharmacy Retailing in China 2010: A Market Analysis
出版日: 2010年07月09日 ページ情報: 英文 125 Pages

当商品の販売は、2016年07月01日を持ちまして終了しました。

概要

中国のOTC医薬品業界は最大かつ最速で拡大しています。OTC医薬品小売市場は2009年に720億2,000万元となりました。2013年には1,000億米ドルを超えるものとみられています。

当レポートでは、中国のOTC薬市場の動向と市場シェア、輸出入動向、薬局小売市場の動向とともに、主要企業のプロファイルを交え、概略下記の構成で取り上げています。

イントロダクション

第1章 中国のOTC薬および薬局小売市場

  • 概要
  • 中国の非食品市場全体
  • 中国のOTC薬市場
    • 概要
    • 市場規模
    • 市場の成長
    • 一人当たりの消費
    • 非食品市場の重要性
  • セクター別動向
    • 小売セクターの価値
    • 小売セクターのシェア
    • 小売セクターの年間成長率
  • 市場シェア
  • 価格
    • 小売価格指標
    • 製品価格
  • 今後の見通し
  • 医薬品の輸出入量
  • 医薬品の輸出入額
  • 医薬品の輸出入平均価格と量

第2章 薬局小売

  • 中国の薬剤小売市場
    • 市場全体の規模
    • 市場成長
    • 医療の重要性
  • セクター別動向
  • 薬局市場
  • 今後の見通し

第3章 企業プロファイル

  • BMP Sonstore Corp
  • China Resource Sanjju Medical & Pharmaceutical Co., Ltd.
  • Harbin Pharm. Group Sanjing Pharmaceutical co., Ltd.
  • Jiangzhong Pharmaceutical Co., Ltd.
  • Sandong Dong-E E-Jian co., Ltd.
  • Sino-American Tianjin SmithKline & French Laboratories Ltd.
  • TibetCheezheng Tibetan Medicine Co., Ltd.
  • Yunnan Baiyao Group Co., Ltd.
  • China Nepstar Chain Drugstore Ltd.
  • Chonuing Tong Jun Ge Co., Ltd.
  • Liaoning Cheng Da Co., Ltd.
  • Shanghai Fosun Pharmaceutical Co., Ltd.
  • Shanghai No. 1 Pharmacy Co., Ltd.
  • Shanghai Pharmaceutical Holding Co., Ltd.
  • Sinopharm Holding Co., Ltd.

第4章 連絡先

  • 業界団体

第5章 関連トレードフェアおよび展示会

  • トレードフェアおよび展示会

付録

目次
Product Code: PHM10

Abstract

DESCRIPTION

This report covers the retail market for western drugs, traditional Chinese medicines, vitamins, minerals & supplements, and other pharmaceutical products sold through the retail channel in China, and the drugstore market.

EXTRACT FROM INTRODUCTION

' ...China has a large and fast-growing OTC pharmaceuticals industry. The total OTC pharmaceuticals retail market increased to RMB72.02bn in 2009, and the market is expected to surpass RMB100bn by 2013. Retail sales value of OTC drugs expanded by 102% between 2003 and 2009.

Increasing public awareness about health care and the importance of self-medication as well as the rapid rise in urban living standards and growing disposable income levels are combining to allow for the increased purchase of OTC pharmaceuticals and consequently propelling growth in the market.

China' s USD 124bn healthcare reform, announced in April 2009, will boost demand for pharmaceutical products ranging from generic drugs to medical equipment. The long-term implication of the healthcare reform on the OTC pharmaceuticals retail market and the pharmacy retailing market is still too early to tell.

However, anecdotal evidence has suggested a 40-60% decline in store traffic in some of the drugstores located in places that have implemented the healthcare reform. As part of the healthcare reform, essential drugs are to be sold at government hospitals at wholesale prices.

Drugstores will benefit immensely from the healthcare reform only when there is a clear separation of drug dispensing and prescribing. In the meantime, drugstores are looking at ways to improve their thinning margins. Some have turned to the internet and some to private label. Most of them are now selling other non-pharmaceutical products such as personal care, family care and convenience products.

The weakness of retail prices, caused by intense competition, continues to put pressure on retailer' s margins, forcing them to consolidate further.

Consolidation is being hampered by the low barrier of entry into this sector. As it is easy for new entrants to come into the market, the country is seeing an oversupply of drugstores. In Guangzhou alone, there is one drugstore for every 1,500 people. As the market share of the top 10 drugstore chains remains low, no chains will be dominating the pharmacy market for the foreseeable future.

In 2009, the drugs retail market stood at RMB136bn, up 119% over 2003. The drugs retail market is expected to grow by 56% in constant value terms between 2010 and 2015. ...'

Table of Contents

INTRODUCTION 1

  • Report Coverage 1
  • Abbreviations Used 1
  • Other Relevant Reports from Access Asia 2
  • China Retail Quarterly 2

1 CHINA' S OTC DRUGS & PHARMACY RETAILING MARKET 3

  • 1.1 Overview 3
  • 1.2 China' s Total Non-Food Market 4
    • 1.2.1 Total Non-Food Market: Food & Non-Food Sales 4
    • Table 1.1 TOTAL CURRENT VALUE RETAIL SALES BY FOOD AND NON-FOOD, 2003-2009 4
    • 1.2.2 Total Non-Food Market: Food/Non-Food Sales Split 4
    • Table 1.2 % BREAKDOWN OF SALES BY FOOD AND NON-FOOD, 2003-2009 4
    • 1.2.3 Total Non-Food Market: Urban/Rural Split 5
    • Table 1.3 TOTAL CURRENT VALUE RETAIL SALES BY FOOD & NON-FOOD, 2003-2009 5
    • 1.2.4 Total Non-Food Market: The Trends 5
    • Table 1.4 CURRENT VALUE OF TOTAL RETAIL NON-FOOD SALES BY MAJOR PRODUCT CATEGORY, 2003-2009 6
  • 1.3 China' s OTC Pharmaceuticals Market 6
    • 1.3.1 OTC Pharmaceuticals Market: Overview 6
    • 1.3.2 OTC Pharmaceuticals Market: Total Market Size 7
    • Figure 1.1: Total OTC Pharmaceuticals Retail Sales Growth, 2003-2009 8
    • Table 1.5 TOTAL RETAIL MARKET FOR OTC PHARMACEUTICALS IN CURRENT AND CONSTANT VALUE TERMS IN CHINA, 2003-2009 8
    • 1.3.3 OTC Pharmaceuticals Market: Total Market Growth 8
    • Table 1.6 % ANNUAL GROWTH OF THE TOTAL OTC PHARMACEUTICALS RETAIL MARKET IN CHINA, 2003-2009 8
    • 1.3.4 OTC Pharmaceuticals Market: Per Capita Consumption 8
    • Table 1.7 TOTAL RETAIL MARKET FOR OTC PHARMACEUTICALS IN CURRENT AND CONSTANT VALUE TERMS IN CHINA, 2003-2009 9
    • 1.3.5 OTC Pharmaceuticals Market: Non-Food Market Significance 9
    • Table 1.8 OTC PHARMACEUTICAL SALES AS A PROPORTION OF TOTAL NON-FOOD EXPENDITURE IN CHINA, 2003-2009 9
  • 1.4 Sector Breakdown 10
    • 1.4.1 Retail Sector Breakdown: Sector Values 10
    • Figure 1.2: Total OTC Pharmaceutical Retail Market Value Sales Growth, 2003-2009 10
    • Table 1.9 TOTAL RETAIL MARKET FOR OTC PHARMACEUTICALS BY SECTOR IN CURRENT VALUE TERMS IN CHINA, 2003-2009 11
    • 1.4.2 Retail Sector Breakdown: Sector Shares 11
    • Table 1.10 % BREAKDOWN OF THE TOTAL RETAIL MARKET FOR OTC PHARMACEUTICALS BY SECTOR IN CURRENT VALUE TERMS IN CHINA, 2003-2009 11
    • 1.4.3 Retail Sector Breakdown: Annual Growth Rates 11
    • Table 1.11 % ANNUAL GROWTH OF THE RETAIL MARKET FOR OTC PHARMACEUTICALS IN CURRENT VALUE TERMS IN CHINA, 2003-2009 11
  • 1.5 Market Shares 12
    • 1.5.1 Market Shares: Ranking of Leading Western OTC Drugs 12
    • Table 1.12 RANKING OF LEADING WESTERN OTC DRUGS IN CHINA, 2009 12
    • 1.5.2 Market Shares: Ranking of Leading Traditional Chinese Medicine OTC Drugs 13
    • Table 1.13 RANKING OF LEADING TRADITIONAL CHINESE MEDICINE OTC DRUGS IN CHINA, 2009 13
    • 1.5.3 Ranking: Top 20 OTC Pharmaceutical Manufacturers 14
    • Table 1.14 TOP 20 OTC PHARMACEUTICAL MANUFACTURERS IN CHINA, 2009 14
    • 1.5.4 Market Shares: Children' s OTC Drugs 14
    • Table 1.15 MARKET SHARE OF TOP CHILDREN' S OTC DRUGS IN CHINA, 2007-2009 14
    • 1.5.5 Market Shares: Cold Medicines 14
    • Table 1.16 MARKET SHARE OF TOP COLD MEDICINES IN CHINA, 2006 14
    • 1.5.6 Market Shares: TCM Antipyretic Granules 15
    • Table 1.17 MARKET SHARE OF TOP TCM ANTIPYRETIC GRANULES IN CHINA, 2008 15
    • 1.5.7 Market Shares: Pharyngeal & Laryngeal Medicines 15
    • Table 1.18 MARKET SHARE OF TOP PHARYNGEAL & LARYNGEAL MEDICINES IN CHINA, 2008 15
    • 1.5.8 Market Shares: External Analgesic 15
    • Table 1.19 MARKET SHARE OF TOP EXTERNAL ANALGESICS IN CHINA, 2008 15
    • 1.5.9 Market Shares: Dermatological 16
    • Table 1.20 MARKET SHARE OF TOP DERMATOLOGICAL MANUFACTURERS IN CHINA, 2005-2007 16
    • 1.5.10 Market Shares: Gastrointestinal 16
    • Table 1.21 MARKET SHARE OF TOP GASTROINTESTINAL DRUGS IN CHINA, 2007 16
    • Table 1.22 MARKET SHARE OF TOP TRADITIONAL CHINESE MEDICINE GASTROINTESTINAL DRUGS IN CHINA, 2007 16
    • 1.5.11 Market Shares: Anti-Allergy 17
    • Table 1.23 MARKET SHARE OF TOP ANTI-ALLERGY DRUGS BY CITIES IN CHINA, 2007-2009 17
    • 1.5.12 Market Shares: Vitamin 18
    • Table 1.24 MARKET SHARE OF TOP VITAMIN MANUFACTURERS BY CITIES, 2007 - 1H2009 18
  • 1.6 Prices 18
    • 1.6.1 Prices: Retail Price Indices 18
    • Table 1.25 AVERAGE INCOME ANNUAL GROWTH BY SECTOR, 2005-2008 19
    • Table 1.26 RETAIL PRICE INDICES BY BROAD SECTOR, 2000-2009 21
    • 1.6.2 Prices: Selected Product Prices 22
    • Table 1.27 RETAIL PRICES OF SELECTED WESTERN ANTI-ALLERGY DRUGS, JUNE 2010 22
    • Table 1.28 RETAIL PRICES OF SELECTED EYE DROPS, JUNE 2010 22
    • Table 1.29 RETAIL PRICES OF SELECTED WESTERN ANTIPYRETIC, ANALGESIC, ANTI-INFLAMMATORY & COLD MEDICINES, JUNE 2010 23
    • Table 1.30 RETAIL PRICES OF SELECTED WESTERN RESPIRATORY DRUGS, JUNE 2010 23
    • Table 1.31 RETAIL PRICES OF SELECTED WESTERN EAR, NOSE & THROAT MEDICINES, JUNE 2010 24
    • Table 1.32 RETAIL PRICES OF SELECTED VITAMINS & SUPPLEMENTS, JUNE 2010 24
    • Table 1.33 RETAIL PRICES OF SELECTED WESTERN DERMATOLOGICAL MEDICINES, JUNE 2010 25
    • Table 1.34 RETAIL PRICES OF SELECTED WESTERN GASTROINTESTINAL MEDICINES, JUNE 2010 26
    • Table 1.35 RETAIL PRICES OF SELECTED TCM COLD MEDICINES, JUNE 2010 26
    • Table 1.36 RETAIL PRICES OF SELECTED TCM GASTROINTESTINAL MEDICINES, JUNE 2010 26
    • Table 1.37 RETAIL PRICES OF SELECTED TCM THROAT MEDICINES, JUNE 2010 27
    • Table 1.38 RETAIL PRICES OF SELECTED TCM HEAT CLEARING & DETOXICATING REMEDIES, JUNE 2010 27
    • Table 1.39 RETAIL PRICES OF SELECTED TCM RESPIRATORY MEDICINES, JUNE 2010 27
    • Table 1.40 RETAIL PRICES OF SELECTED TCM ORTHOPEDIC MEDICINES, JUNE 2010 27
  • 1.7 Outlook 28
    • 1.7.1 Outlook: Forecast Trends 28
    • 1.7.2 Outlook: Total OTC Pharmaceuticals Retail Market Size 28
    • Table 1.41 FORECAST TOTAL VALUE MARKET FOR OTC PHARMACEUTICALS IN CHINA, 2010-2015 28
    • 1.7.3 Outlook: Total Retail Sector Values 28
    • Figure 1.3: Forecast OTC Pharmaceuticals Value Sales Growth by Sector, 2010-2015 29
    • Table 1.42 FORECAST CONSTANT 2009 VALUE SALES OF OTC PHARMACEUTICALS BY SECTOR IN CHINA, 2010-2015 29
    • 1.7.4 Outlook: Total Retail Sector Breakdown 29
    • Table 1.43 FORECAST % VALUE SALES BREAKDOWN OF OTC PHARMACEUTICALS BY SECTOR IN CHINA, 2010-2015 29
    • 1.7.5 Outlook: Total Retail Sector Growth 30
    • Table 1.44 FORECAST ANNUAL % VALUE SALES GROWTH OF OTC PHARMACEUTICALS BY SECTOR IN CHINA, 2010-2015 30
  • 1.8 Pharmaceutical Products Import & Export Volume 30
    • Table 1.45 HS CODE DESCRIPTION 30
    • 1.8.1 Pharmaceutical Products Import & Export Volume: Total Trade Volume 30
    • Table 1.46 CHINA PHARMACEUTICAL PRODUCTS IMPORT & EXPORT VOLUME & GROWTH, 2000-2009 30
    • 1.8.2 Pharmaceutical Products Import & Export Volume: Import Volume 31
    • Table 1.47 VOLUME BREAKDOWN OF CHINA PHARMACEUTICAL PRODUCTS IMPORT, 2000-2009 31
    • 1.8.3 Pharmaceutical Products Import & Export Volume: Export Volume 31
    • Table 1.48 VOLUME BREAKDOWN OF CHINA PHARMACEUTICAL PRODUCTS EXPORT, 2000-2009 31
  • 1.9 Pharmaceutical Products Import & Export Value 31
    • 1.9.1 Pharmaceutical Products Import & Export Value: Total Trade Value 31
    • Table 1.49 CHINA PHARMACEUTICAL PRODUCTS IMPORT & EXPORT VALUE & GROWTH, 2000-2009 31
    • 1.9.2 Pharmaceutical Products Import & Export Value: Import Value 32
    • Table 1.50 VALUE BREAKDOWN OF CHINA PHARMACEUTICAL PRODUCTS IMPORT, 2000-2009 32
    • 1.9.3 Pharmaceutical Products Import & Export Value: Export Value 32
    • Table 1.51 VALUE BREAKDOWN OF CHINA PHARMACEUTICAL PRODUCTS EXPORT, 2000-2009 32
  • 1.10 Pharmaceutical Products Import & Export Average Unit Value 32
    • 1.10.1 Pharmaceutical Products Import & Export Average Unit Value: Overview 32
    • Table 1.52 CHINA PHARMACEUTICAL PRODUCTS IMPORT & EXPORT AVERAGE UNIT VALUE & GROWTH, 2000-2009 32
    • 1.10.2 Pharmaceutical Products Import & Export Average Unit Value: Import 33
    • Table 1.53 AVERAGE UNIT VALUE BREAKDOWN OF CHINA PHARMACEUTICAL PRODUCTS IMPORT, 2000-2009 33
    • 1.10.3 Pharmaceutical Products Import & Export Average Unit Value: Export 33
    • Table 1.54 AVERAGE UNIT VALUE BREAKDOWN OF CHINA PHARMACEUTICAL PRODUCTS EXPORT, 2000-2009 33

2 PHARMACY RETAILING 34

  • 2.1 China' s Drugs Retail Market 34
    • 2.1.1 Drugs Retail Market: Total Market Size 34
    • Figure 2.1: Total Drugs Retail Market Sales Growth, 2003-2009 34
    • Table 2.1 TOTAL DRUGS RETAIL MARKET IN CURRENT AND CONSTANT VALUE TERMS IN CHINA, 2003-2009 34
    • 2.1.2 Drugs Retail Market: Total Market Growth 34
    • Table 2.2 % ANNUAL GROWTH OF THE TOTAL DRUGS RETAIL MARKET IN CHINA, 2003-2009 34
    • 2.1.3 Drugs Retail Market: Medical and Healthcare significance 34
    • Table 2.3 DRUGS RETAIL SALES AS A PROPORTION OF TOTAL MEDICAL & HEALTHCARE EXPENDITURE IN CHINA, 2003-2009 35
  • 2.2 Sector Breakdown 36
    • 2.2.1 Sector Breakdown: Sector Sizes 36
    • Figure 2.2: Total Drugs Retail Market Value Sales Growth, 2003-2009 36
    • Table 2.4 TOTAL DRUGS RETAIL MARKET BY SECTOR IN CURRENT VALUE TERMS IN CHINA, 2003-2009 36
    • 2.2.2 Sector Breakdown: Sector Shares 36
    • Table 2.5 % BREAKDOWN OF THE TOTAL DRUGS RETAIL MARKET BY SECTOR IN CURRENT VALUE TERMS IN CHINA, 2003-2009 36
    • 2.2.3 Sector Breakdown: Sector Growth 37
    • Table 2.6 % ANNUAL GROWTH OF THE TOTAL DRUGS RETAIL MARKET BY SECTOR IN CURRENT VALUE TERMS IN CHINA, 2003-2009 37
  • 2.3 Pharmacy Market 37
    • 2.3.1 Pharmacy Market: Number of Stores 37
    • Table 2.7 CHINA PHARMACY RETAIL OUTLETS BY OWNERSHIP STRUCTURE, 2006-2008 38
    • 2.3.2 Pharmacy Market: Top 100 Pharmacy Chains 38
    • Table 2.8 PHARMACY RETAIL SALES BY THE TOP-100, -50, -30 % -10 PHARMACY CHAINS IN CHINA, 2003-2009 38
    • 2.3.3 Pharmacy Market: Market Shares 39
    • Table 2.9 TOP 10 PHARMACY RETAIL CHAINS % SHARE OF DRUGSTORE SALES, 2003-2009 39
    • 2.3.4 Pharmacy Market: Revenue of Top 25 Pharmacy Chains 39
    • Table 2.10 RANKING OF TOP 25 PHARMACIES BY REVENUE IN CHINA, 2003-2009 39
    • Table 2.11 REVENUE OF TOP 25 PHARMACIES IN CHINA, 2003-2009 40
    • 2.3.5 Pharmacy Market: Revenue Growth of Top 25 Pharmacy Chains 40
    • Table 2.12 REVENUE GROWTH RATE OF TOP 25 PHARMACIES BY REVENUE IN CHINA, 2003-2009 41
    • 2.3.6 Pharmacy Market: Store Network of Top 25 Pharmacy Chains by Revenue 41
    • Table 2.13 TOP STORE NETWORK OF 25 LEADING PHARMACIES BY REVENUE IN CHINA, 2003-2009 41
    • 2.3.7 Pharmacy Market: Average Revenue Per Store of Top 25 Pharmacy Chains by Revenue 42
    • Table 2.14 AVERAGE REVENUER PER STORE OF TOP 25 PHARMACIES BY REVENUE IN CHINA, 2003-2009 42
    • 2.3.8 Pharmacy Market: Top 20 Pharmacies by Number of Franchise Outlets 43
    • Table 2.15 TOP 20 PHARMACIES IN CHINA BY THE NUMBER OF FRANCHISE STORES, 2008 43
    • Table 2.16 TOP 20 PHARMACIES IN CHINA BY THE NUMBER OF FRANCHISE STORES, 2009 43
    • 2.3.9 Pharmacy Market: Top 20Pharmacies by Number of Directly Operated Outlets 44
    • Table 2.17 TOP 20 PHARMACIES IN CHINA BY THE NUMBER OF DIRECTLY OPERATED STORES, 2008 44
    • Table 2.18 TOP 20 PHARMACIES IN CHINA BY THE NUMBER OF DIRECTLY OPERATED STORES, 2009 44
    • 2.3.10 Pharmacy Market: Diversification 45
    • Table 2.19 SHARE OF NON-DRUGS IN PHARMACY RETAILING, 2009 46
    • 2.3.11 Pharmacy Market: Internet Pharmacies 47
    • Table 2.20 GOVERNMENT-APPROVED ONLINE PHARMACIES, AS OF 16 JUNE 2010 47
    • Table 2.21 ILLEGAL DRUG SELLING WEBSITES IN CHINA, 2008-2010 48
    • 2.3.12 Pharmacy Market: Profit Margins 49
    • Table 2.22 GROSS PROFIT MARGINS OF SELECTED PHARMACIES IN CHINA, 2006-2009 49
    • Table 2.23 GROSS PROFIT MARGINS OF SELECTED PHARMARCIES IN CHINA, 2009 50
    • Table 2.24 NET PROFIT MARGINS OF SELECTED PHARMACIES IN CHINA, 2006-2009 50
    • Table 2.25 TOP 10 PHARMACIES IN CHINA BY PRE-TAX PROFIT MARGINS, 2008 51
    • Table 2.26 TOP 10 PHARMACIES IN CHINA BY PRE-TAX PROFITS, 2009 51
    • Table 2.27 PRE-TAX PROFIT MARGINS OF SELECTED PHARMACIES IN CHINA, 2009 51
    • 2.3.13 Pharmacy Market: Private Label 52
    • Table 2.28 SHARE OF PRIVATE LABEL OR HIGH MARGIN PRODUCTS OF DRUGSTORE CHAINS, 2009 52
    • Nepstar 52
    • Table 2.29 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: NUMBER OF PRIVATE LABEL PRODUCTS, 2006-2009* 52
    • Table 2.30 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: PRIVATE LABEL REVENUE SHARE, 2006-2009 53
    • Watsons 53
    • 2.3.14 Pharmacy Market: Health & Beauty Chain Developments 54
    • Table 2.31 MANNINGS STORES IN CHINA, 2003-2009 55
    • Table 2.32 WATSONS STORES IN CHINA 55
    • 2.3.15 Pharmacy Market: Mergers & Acquisitions 56
    • Table 2.33 SELECTED MERGERS & ACQUISITIONS IN CHINA, 2009-JUNE 2010 57
  • 2.4 Outlook 58
    • 2.4.1 Outlook: Forecast Trends 58
    • 2.4.2 Outlook: Total Drugs Retail Market Size 58
    • Table 2.34 FORECAST TOTAL VALUE FOR DRUGS RETAIL MARKET IN CHINA, 2010-2015 58
    • 2.4.3 Outlook: Total Drugs Retail Sector Values 58
    • Figure 2.3: Forecast Drugs Retail Value Sales Growth by Sector, 2010-2015 59
    • Table 2.35 FORECAST CONSTANT 2009 VALUE SALES OF DRUGS RETAIL MARKET BY SECTOR IN CHINA, 2010-2015 59
    • 2.4.4 Outlook: Total Drugs Retail Sector Breakdown 59
    • Table 2.36 FORECAST % VALUE SALES BREAKDOWN OF DRUGS RETAIL MARKET BY SECTOR IN CHINA, 2010-2015 59
    • 2.4.5 Outlook: Total Drugs Retail Sector Growth 59
    • Table 2.37 FORECAST ANNUAL % VALUE SALES GROWTH OF DRUGS RETAIL MARKET BY SECTOR IN CHINA, 2010-2015 59

3 COMPANY PROFILES 60

OTC Pharmaceutical Manufacturers 60

  • 3.1 BMP Sunstone Corp. 60
    • 3.1.1 BMP Sunstone: Company Details 60
    • 3.1.2 BMP Sunstone: Company Background 60
    • Table 3.1 BMP SUNSTONE CORP.: % BREAKDOWN OF NET REVENUE BY PRODUCT SEGMENT, 2008-2009 60
    • Table 3.2 BMP SUNSTONE CORP.: REVENUE BY BUSINESS, 2006-2009 61
    • 3.1.3 BMP Sunstone: Financial Results 61
    • Table 3.3 BMP SUNSTONE CORP.: FINANCIAL RESULTS, 2004-2009* 61
    • Table 3.4 BMP SUNSTONE CORP.: % BREAKDOWN OF TOTAL REVENUE, 2004-2009* 62
  • 3.2 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. 62
    • 3.2.1 China Resources Sanjiu Medical & Pharmaceutical: Company Details 62
    • 3.2.2 China Resources Sanjiu Medical & Pharmaceutical: Company Background 62
    • Table 3.5 CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.: BREAKDOWN OF MAIN OPERATING REVENUE BY BUSINESS SEGMENT, 2007-2009 63
    • 3.2.2 China Resources Sanjiu Medical & Pharmaceutical: Financial Results 63
    • Table 3.6 CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2006-2009* 63
    • Table 3.7 CHINA RESOURCES SANJIU MEDICAL & PHARMACEUTICAL CO., LTD.: % BREAKDOWN OF TOTAL REVENUE, 2006-2009* 64
  • 3.3 Harbin Pharm. Group Sanjing Pharmaceutical Co., Ltd. 64
    • 3.3.1 Harbin Pharm. Group Sanjin Pharmaceutical: Company Details 64
    • 3.3.2 Harbin Pharm. Group Sanjin Pharmaceutical: Company Background 64
    • Table 3.8 HARBIN PHARM. GROUP SANJING PHARMACEUTICAL CO., LTD.: MAIN OPERATING REVENUE BY BUSINESS SEGMENT, 2006-2009 65
    • Table 3.9 HARBIN PHARM. GROUP SANJING PHARMACEUTICAL CO., LTD.: MAIN OPERATING REVENUE BY GEOGRAPHICAL MARKET, 2006-2009* 65
    • 3.3.3 Harbin Pharm. Group Sanjin Pharmaceutical: Financial Results 66
    • Table 3.10 HARBIN PHARM. GROUP SANJING PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2006-2009* 66
    • Table 3.11 HARBIN PHARM. GROUP SANJING PHARMACEUTICAL CO., LTD.: % BREAKDOWN OF TOTAL REVENUE, 2006-2009* 66
  • 3.4 Jiangzhong Pharmaceutical Co., Ltd. 67
    • 3.4.1 Jiangzhong Pharmaceutical: Company Details 67
    • 3.4.2 Jiangzhong Pharmaceutical: Company Background 67
    • Table 3.12 JIANGZHONG PHARMACEUTICAL CO., LTD.: REVENUES OF OTC PRODUCTS, 2005-2009 67
    • Table 3.13 JIANGZHONG PHARMACEUTICAL CO., LTD.: MAIN OPERATING REVENUE BREAKDOWN BY BUSINESS SEGMENT, 2006-2009 68
    • Table 3.14 JIANGZHONG PHARMACEUTICAL CO., LTD.: MAIN OPERATING REVENUE BREAKDOWN BY GEOGRAPHICAL MARKET, 2006-2009 68
    • 3.4.3 Jiangzhong Pharmaceutical: Financial Results 69
    • Table 3.15 JIANGZHONG PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS, 2006-2009* 69
    • Table 3.16 JIANGZHONG PHARMACEUTICAL CO., LTD.: % BREAKDOWN OF TOTAL REVENUE, 2006-2009* 69
  • 3.5 Shandong Dong-E E-Jiao Co., Ltd. 70
    • 3.5.1 Shandong Dong-E E-Jiao: Company Details 70
    • 3.5.2 Shandong Dong-E E-Jiao: Company Background 70
    • Table 3.17 SHANDONG DONG-E E-JIAO CO., LTD.: MAIN OPERATING REVENUE BY BUSINESS SEGMENT, 2006-2007 70
    • Table 3.18 SHANDONG DONG-E E-JIAO CO., LTD.: MAIN OPERATING REVENUE BY PRODUCT SEGMENT, 2007-2009 71
    • 3.5.3 Shandong Dong-E E-Jiao: Financial Results 71
    • Table 3.19 SHANDONG DONG-E E-JIAO CO., LTD.: FINANCIAL RESULTS, 2006-2009* 72
    • Table 3.20 SHANDONG DONG-E E-JIAO CO., LTD.: % BREAKDOWN OF TOTAL REVENUE, 2006-2009* 72
  • 3.6 Sino-American Tianjin Smith Kline & French Laboratories Ltd. (TSKF) 73
    • 3.6.1 Sino-American Tianjin Smith Kline & French Laboratories: Company Details 73
    • 3.6.2 Sino-American Tianjin Smith Kline & French Laboratories: Company Background 73
    • Table 3.21 GLAXOSMITHKLINE (CHINA) INVESTMENT CO., LTD.: KEY OTC MEDICINES & CONSUMER HEALTHCARE PRODUCTS IN CHINA 73
    • 3.6.3 Sino-American Tianjin Smith Kline & French Laboratories: Financial Results 74
    • Table 3.22 SINO-AMERICAN TIANJIN SMITH KLINE & FRENCH LABORATORIES LTD.: FINANCIAL RESULTS, 2002-2009* 74
  • 3.7 Tibet Cheezheng Tibetan Medicine Co., Ltd. 74
    • 3.7.1 Tibet Cheezheng Tibetan Medicine: Company Details 74
    • 3.7.2 Tibet Cheezheng Tibetan Medicine: Company Background 74
    • Table 3.23 TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.: MAIN OPERATING REVENUE BY PRODUCT SEGMENT, 2006-2009 75
    • Table 3.24 TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.: MAIN OPERATING REVENUE BY GEOGRAPHICAL REGION, 2006-2009* 75
    • 3.7.3 Tibet Cheezheng Tibetan Medicine: Financial Results 75
    • Table 3.25 TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.: FINANCIAL RESULTS, 2006-2009* 76
    • Table 3.26 TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.: % BREAKDOWN OF TOTAL REVENUE, 2006-2009* 76
  • 3.8 Yunnan Baiyao Group Co., Ltd. 77
    • 3.8.1 Yunnan Baiyao Group: Company Details 77
    • 3.8.2 Yunnan Baiyao Group: Company Background 77
    • Table 3.27 YUNNAN BAIYAO GROUP CO., LTD.: MAIN OPERATING REVENUE BY BUSINESS, 2007-2009* 77
    • Table 3.28 YUNNAN BAIYAO GROUP CO., LTD.: MAIN OPERATING REVENUE BY GEOGRAPHICAL MARKET, 2007-2009* 78
    • 3.8.3 Yunnan Baiyao Group: Financial Results 78
    • Table 3.29 YUNNAN BAIYAO GROUP CO., LTD.: FINANCIAL RESULTS, 2006-2009* 78
    • Table 3.30 YUNNAN BAIYAO GROUP CO., LTD.: % BREAKDOWN OF TOTAL REVENUE, 2006-2009* 79
    • Pharmaceutical Distributors and Retailers 79
  • 3.9 China Nepstar Chain Drugstore Ltd. 79
    • 3.9.1 China Neptar Chain Drugstore: Company Details 79
    • 3.9.2 China Neptar Chain Drugstore: Company Background 79
    • Table 3.31 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: DETAILS ON STORE OPENING, CLOSURE & ACQUISITION, 2004-2009 80
    • Table 3.32 CHINA NEPSTAR DRUGSTORE LTD.: % BREAKDOWN OF OUTLET BY CITY, 2004-2009 80
    • Table 3.33 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: REVENUE BREAKDOWN BY PRODUCT CATEGORY, 2004-2009 81
    • Table 3.34 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: NUMBER OF PRIVATE LABEL PRODUCTS, 2006-2009* 81
    • Table 3.35 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: PRIVATE LABEL REVENUE SHARE, 2006-2009 81
    • Table 3.36 CHINA NEPSTAR DRUGSTORE LTD.: LOYALTY SCHEME MEMBERS, 2005-2009* 82
    • Table 3.37 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: YEARLY SAME STORE SALES, 2007-2009* 82
    • Table 3.38 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: QUARTERLY SAME STORE SALES, 2007-2009* 82
    • Table 3.39 CHINA NEPSTAR DRUGSTORE LTD.: NUMBER OF EMPLOYEES, 2004-2009 82
    • 3.9.2 China Neptar Chain Drugstore: Financial Results 83
    • Table 3.40 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: FINANCIAL RESULTS, 2004-2009* 83
    • Table 3.41 CHINA NEPSTAR CHAIN DRUGSTORE LTD.: BREAKDOWN OF FINANCIAL RESULTS, 2004-2009* 84
  • 3.10 Chongqing Tong Jun Ge Co., Ltd. 85
    • 3.10.1 Chongqing Tong Jun Ge: Company Details 85
    • 3.10.2 Chongqing Tong Jun Ge: Company Background 85
    • Table 3.42 CHONGQING TONG JUN GE CO., LTD.: REVENUE BY BUSINESS SEGMENT, 2006-2009 85
    • Table 3.43 CHONGQING TONG JUN GE CO., LTD.: NET PROFIT OF KEY PHARMACEUTICAL RETAIL SUBSIDIARIES, 2004-2009 85
    • Table 3.44 CHONGQING TONG JUN GE DRUGSTORE CO., LTD.: NUMBER OF STORES, 2003-2009 86
    • Table 3.45 SICHUAN TIANCHENG DRUGSTORE CO., LTD.: NUMBER OF STORES, 2003-2009 86
    • Table 3.46 SICHUAN TAIJI DRUGSTORE CO., LTD.: NUMBER OF STORES, 2005-2009 86
    • 3.10.3 Chongqing Tong Jun Ge: Financial Results 86
    • Table 3.47 CHONGQING TONG JUN GE DRUGSTORE CO., LTD.: FINANCIAL RESULTS, 2003-2009 86
    • Table 3.48 SICHUAN TIANCHENG DRUGSTORE CO., LTD.: FINANCIAL RESULTS, 2003-2009 87
    • Table 3.49 SICHUAN TAIJI DRUGSTORE CO., LTD.: FINANCIAL RESULTS, 2005-2009 87
    • Table 3.50 CHONGQING TONG JUN GE CO., LTD.: FINANCIAL RESULTS, 2006-2009* 87
    • Table 3.51 CHONGQING TONG JUN GE CO., LTD.: BREAKDOWN OF FINANCIAL RESULTS, 2006-2009* 88
  • 3.11 Liaoning Cheng Da Co., Ltd. 88
    • 3.11.1 Liaoning Cheng Da: Company Details 88
    • 3.11.2 Liaoning Cheng Da: Company Background 88
    • Table 3.52 LIAONING CHENGDA FANGYUAN PHARMACY CHAIN CO., LTD.: STORE NETWORK, 2003-2009* 89
    • Table 3.53 LIAONING CHENG DA CO., LTD.: REVENUE BY BUSINESS SEGMENT, 2006-2009 89
    • 3.11.3 Liaoning Cheng Da: Financial Results 90
    • Table 3.54 LIAONING CHENGDA FANGYUAN PHARMACY CHAIN CO., LTD.: FINANCIAL RESULTS, 2007-2009* 90
    • Table 3.55 LIAONING CHENGDA FANGYUAN PHARMACY CHAIN CO., LTD.: FINANCIAL RESULTS, 2003-2009* 90
    • Table 3.56 LIAONING CHENG DA CO., LTD.: FINANCIAL RESULTS, 2006-2009* 90
    • Table 3.57 LIAONING CHENG DA CO., LTD.: BREAKDOWN OF FINANCIAL RESULTS, 2006-2009* 91
  • 3.12 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 91
    • 3.12.1 Shanghai Fosun Pharmaceutical (Group): Company Details 91
    • 3.12.2 Shanghai Fosun Pharmaceutical (Group): Company Background 91
    • Table 3.58 SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.: REVENUE BY BUSINESS SEGMENT, 2006-2009 92
    • Table 3.59 SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.: REVENUE & NET PROFIT OF KEY PHARMACEUTICAL RETAILING UNITS AND ASSOCIATES, 2006-2009 92
    • Table 3.60 SHANGHAI FUMEI YIXING DRUGSTORE CO., LTD.: NUMBER OF STORES, 2003-2009 92
    • Table 3.61 BEIJING GOLDEN ELEPHANT DRUGSTORE CO., LTD.: NUMBER OF STORES, 2003-2009 93
    • Table 3.62 SHANGHAI YAOFANG CO., LTD.: NUMBER OF STORES, 2003-2009 93
    • 3.12.3 Shanghai Fosun Pharmaceutical (Group): Financial Results 93
    • Table 3.63 SHANGHAI FUMEI YIXING DRUGSTORE CO., LTD.: FINANCIAL RESULTS, 2003-2009 93
    • Table 3.64 BEIJING GOLDEN ELEPHANT DRUGSTORE CO., LTD.: FINANCIAL RESULTS, 2003-2009 93
    • Table 3.65 SHANGHAI YAOFANG CO., LTD.: FINANCIAL RESULTS, 2003-2009 94
    • Table 3.66 SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.: FINANCIAL RESULTS, 2006-2009* 94
    • Table 3.67 SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.: BREAKDOWN OF FINANCIAL RESULTS, 2006-2009* 95
  • 3.13 Shanghai No.1 Pharmacy Co., Ltd. 95
    • 3.13.1 Shanghai No.1 Pharmacy: Company Details 95
    • 3.13.2 Shanghai No.1 Pharmacy: Company Background 95
    • Table 3.68 SHANGHAI NO.1 PHARMACY CO., LTD.: REVENUE BY BUSINESS SEGMENT, 2002-2009 96
    • Table 3.69 SHANGHAI NO.1 PHARMACY CO., LTD.: REVENUE OF KEY SUBSIDIARIES, 2007-2009 96
    • 3.13.3 Shanghai No.1 Pharmacy: Financial Results 96
    • Table 3.70 SHANGHAI NO.1 PHARMACY CO., LTD.: FINANCIAL RESULTS, 2006-2009* 96
    • Table 3.71 SHANGHAI NO.1 PHARMACY CO., LTD.: BREAKDOWN OF FINANCIAL RESULTS, 2006-2009* 97
  • 3.14 Shanghai Pharmaceutical Holding Co., Ltd. 97
    • 3.14.1 Shanghai Pharmaceutical Holding: Company Details 97
    • 3.14.2 Shanghai Pharmaceutical Holding: Company Background 97
    • Table 3.72 SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.: MAIN OPERATING REVENUE BREAKDOWN BY BUSINESS SEGMENT, 2009* 98
    • Table 3.73 SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.: PHARMACY DISTRIBUTION, 2009* 98
    • Table 3.74 SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.: REVENUE OF KEY SUBSIDIARIES & INVESTED FIRMS, 2009 99
    • Table 3.75 SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.: REVENUE OF OTHER INVESTED PHARMACY RETAILERS, 2009 99
    • 3.14.3 Shanghai Pharmaceutical Holding: Financial Results 99
    • Table 3.76 SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.: FINANCIAL RESULTS, 2008-2009* 99
  • 3.15 Sinopharm Holding Co., Ltd. 100
    • 3.15.1 Sinopharm Holding: Company Details 100
    • 3.15.2 Sinopharm Holding: Company Background 100
    • Table 3.77 SINOPHARM HOLDING CO., LTD.: RETAIL NETWORK, 2006-MAY 2009 100
    • Table 3.78 SINOPHARM HOLDING CO., LTD.: DETAILS ON RETAIL PHARMACY OPENING, CLOSURE & ACQUISITION, 2006-MAY 2009 101
    • Table 3.79 SINOPHARM HOLDING CO., LTD.: REVENUE BREAKDOWN BY BUSINESS SEGMENT, 2006-2009 101
    • Table 3.80 SINOPHARM HOLDING GUODA DRUG STORE CO., LTD.: RETAIL NETWORK, 2006- 2009 102
    • Table 3.81 SINOPHARM HOLDING CO., LTD.: PRINCIPAL SUBSIDIARIES & ASSOCIATES, 2009 102
    • 3.15.3 Sinopharm Holding: Financial Results 102
    • Table 3.82 SINOPHARM HOLDING GUODA DRUG STORE CO., LTD.: FINANCIAL RESULTS, 2006- 2009 103
    • Table 3.83 SHENZHEN ACCORD PHARMACEUTICAL CO., LTD.: FINANCIAL RESULTS (PHARMACEUTICAL RETAILING SEGMENT), 2006- 2009* 103
    • Table 3.84 SINOPHARM HOLDING CO., LTD.: FINANCIAL RESULTS, 2006-2009* 103
    • Table 3.85 SINOPHARM HOLDING CO., LTD.: BREAKDOWN OF FINANCIAL RESULTS, 2006-2009* 104

4 CONTACTS 105

  • 4.1 Trade Organisations 105
    • China Pharmaceutical Enterprises Association 105
    • China Nonprescription Medicines Association 105
    • China Chamber of Commerce for Import & Export of Medicines & Health Products 105
    • China Health Care Association 105
    • China Association of Pharmaceutical Commerce 105

5 RELEVANT TRADE FAIRS & EXHIBITIONS 106

  • 5.1 Trade Fairs & Exhibitions 106
    • China Drugstore Show 106
    • China International Medicinal Equipment Fair 106
    • China International Pharmaceutical Industry Exhibition 106
    • China International Pharmaceutical Ingredients Fair 106
    • China National Pharmaceuticals Fair (Pharm China) 106
    • Personal Care & Homecare Ingredients 107
    • CPhI China 107

APPENDIX: MARKET BACKGROUND 108

  • A.1 Fast Facts 108
  • A.2 Population 109
    • A.2.1 Population: By Age Group & Gender 109
    • Table A.1 POPULATION BY AGE GROUP & GENDER, 2003 - 2009* 109
    • A.2.2 Population: By Province 110
    • Table A.2 POPULATION BY PROVINCE, 2003 - 2009* 110
  • A.3 Exchange Rates 111
    • A.3.1 Exchange Rates: China 111
    • Table A.3 AVERAGE ANNUAL RENMINBI EXCHANGE RATES AGAINST A VARIETY OF CURRENCIES, 2002 - 2009 111
    • A.3.2 Exchange Rates: Hong Kong 111
    • Table A.4 AVERAGE ANNUAL HONG KONG DOLLAR EXCHANGE RATES AGAINST THE UNITED STATES DOLLAR AND RENMINBI, 2002 - 2009 111
Back to Top